KLOX Technologies reports on final results from its clinical study on LumiHeal™ for the treatment of chronic wounds
KLOX Technologies reports on final results from its clinical study on LumiHeal™ for the treatment of chronic woundsMay 3, 2017Laval, Quebec, May 3rd, 2017 (GLOBE NEWSWIRE) – Today, the final results on KLOX Technologies’ (Klox) EUREKA study, which evaluated Read More

Preliminary results for Phovia™ in the treatment of Canine Chronic Otitis to be presented at ECVS scientific meeting
Preliminary results for Phovia™ in the treatment of Canine Chronic Otitis to be presented at ECVS scientific meetingMarch 27, 2017DUBLIN, Ireland, March 24, 2017 (GLOBE NEWSWIRE) — Klox Technologies Limited, a subsidiary of Klox Technologies Inc. (‘Klox’) hasRead More

Klox Technologies and LEO Pharma set up company for BioPhotonic in dermatology
Klox Technologies and LEO Pharma set up company for BioPhotonic in dermatologyMarch 6, 2017Laval, Québec, Canada, and Ballerup, Denmark March 6th. Klox Technologies Inc. (‘Klox’) and LEO Pharma A/S (‘LEO Pharma’) to establRead More